Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/CE

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/CE(x) 1.572.651.973.003.43

What is the latest EV/CE ratio of NATCO PHARMA ?

The latest EV/CE ratio of NATCO PHARMA is 1.57 based on Mar2025 Consolidated results.
Year EV/CE
Mar20251.57
Mar20242.65
Mar20231.97
Mar20223.00
Mar20213.43

How is EV/CE of NATCO PHARMA Trending?

Years EV/CE % Change
Mar2025 1.57
-40.75
Mar2024 2.65
34.52
Mar2023 1.97
-34.33
Mar2022 3
-12.54
Mar2021 3.43 -

Other Financial Ratios of NATCO PHARMA


Compare EV/CE ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,744.4 Cr -0% -13.1% -29.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-0%

-13.1%

-29.8%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses